| pubmed-article:15750713 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15750713 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:15750713 | lifeskim:mentions | umls-concept:C0030956 | lld:lifeskim |
| pubmed-article:15750713 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:15750713 | lifeskim:mentions | umls-concept:C1293122 | lld:lifeskim |
| pubmed-article:15750713 | lifeskim:mentions | umls-concept:C0525038 | lld:lifeskim |
| pubmed-article:15750713 | lifeskim:mentions | umls-concept:C1413106 | lld:lifeskim |
| pubmed-article:15750713 | lifeskim:mentions | umls-concept:C1136254 | lld:lifeskim |
| pubmed-article:15750713 | lifeskim:mentions | umls-concept:C0671062 | lld:lifeskim |
| pubmed-article:15750713 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:15750713 | pubmed:dateCreated | 2005-3-7 | lld:pubmed |
| pubmed-article:15750713 | pubmed:abstractText | Mammalian myeloid and epithelial cells express various peptide antibiotics (such as defensins and cathelicidins) that contribute to the innate host defense against invading micro-organisms. Among these, human cathelicidin CAP18/LL-37 (L1-S37) possesses potent antibacterial activities against Gram-positive and Gram-negative bacteria. In this study, to develop peptide derivatives with improved bactericidal actions, we utilized the amphipathic 18-mer peptide (K15-V32) of LL-37 as a template, and evaluated the activities of modified peptides. | lld:pubmed |
| pubmed-article:15750713 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15750713 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15750713 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15750713 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15750713 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15750713 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15750713 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15750713 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:15750713 | pubmed:issn | 1023-3830 | lld:pubmed |
| pubmed-article:15750713 | pubmed:author | pubmed-author:HirataMM | lld:pubmed |
| pubmed-article:15750713 | pubmed:author | pubmed-author:TamuraHH | lld:pubmed |
| pubmed-article:15750713 | pubmed:author | pubmed-author:HiramatsuKK | lld:pubmed |
| pubmed-article:15750713 | pubmed:author | pubmed-author:NagaokaII | lld:pubmed |
| pubmed-article:15750713 | pubmed:author | pubmed-author:Kuwahara-Arai... | lld:pubmed |
| pubmed-article:15750713 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15750713 | pubmed:volume | 54 | lld:pubmed |
| pubmed-article:15750713 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15750713 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15750713 | pubmed:pagination | 66-73 | lld:pubmed |
| pubmed-article:15750713 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:15750713 | pubmed:meshHeading | pubmed-meshheading:15750713... | lld:pubmed |
| pubmed-article:15750713 | pubmed:meshHeading | pubmed-meshheading:15750713... | lld:pubmed |
| pubmed-article:15750713 | pubmed:meshHeading | pubmed-meshheading:15750713... | lld:pubmed |
| pubmed-article:15750713 | pubmed:meshHeading | pubmed-meshheading:15750713... | lld:pubmed |
| pubmed-article:15750713 | pubmed:meshHeading | pubmed-meshheading:15750713... | lld:pubmed |
| pubmed-article:15750713 | pubmed:meshHeading | pubmed-meshheading:15750713... | lld:pubmed |
| pubmed-article:15750713 | pubmed:meshHeading | pubmed-meshheading:15750713... | lld:pubmed |
| pubmed-article:15750713 | pubmed:meshHeading | pubmed-meshheading:15750713... | lld:pubmed |
| pubmed-article:15750713 | pubmed:meshHeading | pubmed-meshheading:15750713... | lld:pubmed |
| pubmed-article:15750713 | pubmed:meshHeading | pubmed-meshheading:15750713... | lld:pubmed |
| pubmed-article:15750713 | pubmed:meshHeading | pubmed-meshheading:15750713... | lld:pubmed |
| pubmed-article:15750713 | pubmed:meshHeading | pubmed-meshheading:15750713... | lld:pubmed |
| pubmed-article:15750713 | pubmed:meshHeading | pubmed-meshheading:15750713... | lld:pubmed |
| pubmed-article:15750713 | pubmed:meshHeading | pubmed-meshheading:15750713... | lld:pubmed |
| pubmed-article:15750713 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15750713 | pubmed:articleTitle | Augmentation of the bactericidal activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by amino acid substitutions. | lld:pubmed |
| pubmed-article:15750713 | pubmed:affiliation | Department of Host Defense and Biochemical Research, School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan. nagaokai@med.juntendo.ac.jp | lld:pubmed |
| pubmed-article:15750713 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15750713 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15750713 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15750713 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15750713 | lld:pubmed |
